Terms: = Uterine cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Diagnosis
18 results:
1. Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
Nyabigambo A; Mayega RW; Ginindza TG
Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623195
[TBL] [Abstract] [Full Text] [Related]
2. Lung metastases and subsequent malignant transformation of a fumarate hydratase -deficient uterine leiomyoma.
Ahvenainen T; Khamaiseh S; Alkodsi A; Mehine M; Nevala R; Äyräväinen A; Bützow R; Vahteristo P
Exp Mol Pathol; 2022 Jun; 126():104760. PubMed ID: 35367216
[TBL] [Abstract] [Full Text] [Related]
3. B7-H4 Expression in Precancerous Lesions of the uterine Cervix.
Zhang Q; Zong L; Zhang H; Xie W; Yang F; Sun W; Cui B; Zhang Y
Biomed Res Int; 2021; 2021():5857092. PubMed ID: 34651047
[TBL] [Abstract] [Full Text] [Related]
4. Endogenous microRNA triggered enzyme-free DNA logic self-assembly for amplified bioimaging and enhanced gene therapy via in situ generation of siRNAs.
Jiang Q; Yue S; Yu K; Tian T; Zhang J; Chu H; Cui Z; Bi S
J Nanobiotechnology; 2021 Sep; 19(1):288. PubMed ID: 34565382
[TBL] [Abstract] [Full Text] [Related]
5. Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer.
Beilner D; Kuhn C; Kost BP; Vilsmaier T; Vattai A; Kaltofen T; Mahner S; Schmoeckel E; Dannecker C; Jückstock J; Mayr D; Jeschke U; Heidegger HH
Arch Gynecol Obstet; 2021 Nov; 304(5):1307-1314. PubMed ID: 33861372
[TBL] [Abstract] [Full Text] [Related]
6. Neurofibrosarcoma Revisited: An Institutional Case Series of uterine Sarcomas Harboring Kinase-related Fusions With Report of a Novel fgfr1-TACC1 Fusion.
Devereaux KA; Weiel JJ; Mills AM; Kunder CA; Longacre TA
Am J Surg Pathol; 2021 May; 45(5):638-652. PubMed ID: 33481389
[TBL] [Abstract] [Full Text] [Related]
7. Digital Quantification of Ki-67 and PHH3 in the Classification of uterine Smooth Muscle Tumors.
Cao CD; Rico-Castillo J; De Cotiis D; Richard SD; Rosenblum NG; Chan JSY
Int J Gynecol Pathol; 2021 Nov; 40(6):549-555. PubMed ID: 33323861
[TBL] [Abstract] [Full Text] [Related]
8. Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
[TBL] [Abstract] [Full Text] [Related]
9. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors.
Teixeira SR; Abreu CM; Parkes L; Davies J; Yao S; Sawhney MA; Margarit L; Gonzalez D; Pinto IM; Francis LW; Conlan RS
Biosens Bioelectron; 2019 Sep; 141():111386. PubMed ID: 31220725
[TBL] [Abstract] [Full Text] [Related]
10. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.
Tandon B; Hagemann IS; Maluf HM; Pfeifer JD; Al-Kateb H
Int J Gynecol Pathol; 2017 Nov; 36(6):593-599. PubMed ID: 28177947
[TBL] [Abstract] [Full Text] [Related]
11. The role of aberrant methylation of trophoblastic stem cell origin in the pathogenesis and diagnosis of placental disorders.
Rahat B; Najar RA; Hamid A; Bagga R; Kaur J
Prenat Diagn; 2017 Feb; 37(2):133-143. PubMed ID: 27885689
[TBL] [Abstract] [Full Text] [Related]
12. The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study.
Chow KL; Tse KY; Cheung CL; Wong KW; Cheung AN; Wong RW; Chan AN; Yuen NW; Ngan HY; Ip PP
Histopathology; 2017 Apr; 70(5):746-755. PubMed ID: 27864989
[TBL] [Abstract] [Full Text] [Related]
13. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.
Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133
[TBL] [Abstract] [Full Text] [Related]
14. Term delivery of a complete hydatidiform mole with a coexisting living fetus followed by successful treatment of maternal metastatic gestational trophoblastic disease.
Peng HH; Huang KG; Chueh HY; Adlan AS; Chang SD; Lee CL
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):397-400. PubMed ID: 25286799
[TBL] [Abstract] [Full Text] [Related]
15. Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.
Wang YS; Cao R; Jin H; Huang YP; Zhang XY; Cong Q; He YF; Xu CJ
J Hematol Oncol; 2011 Apr; 4():15. PubMed ID: 21489304
[TBL] [Abstract] [Full Text] [Related]
16. [Comparison of gastrointestinal toxicity in patients with advanced cervical carcinoma treated with concomitant chemotherapy and radiotherapy versus radiotherapy alone].
Kantaradzić N; Beslija S; Kalamujić M
Med Arh; 2004; 58(4):214-7. PubMed ID: 15526587
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic features of endometrial cancer in estrogen users and obese women.
La Vecchia C; Franceschi S; Gallus G; Decarli A; Colombo E; Liberati A; Tognoni G
Am J Obstet Gynecol; 1982 Oct; 144(4):387-90. PubMed ID: 7124857
[TBL] [Abstract] [Full Text] [Related]
18. Estrogen metabolism in patients at high risk for endometrial carcinoma. I. Urinary metabolites of H3-estradiol in normal postmenopausal women and those with endometrial carcinoma.
Hausknecht RU; Gusberg SB
Am J Obstet Gynecol; 1969 Dec; 105(8):1161-7. PubMed ID: 5360244
[TBL] [Abstract] [Full Text] [Related]
